RxDoctor Payments Data

Jaimie Wotell

Medical · Millersville, MDNPI 1740530500

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 483 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,971in general payments, 2019–2025

Across 483 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • LEO Pharma Inc.$847
  • Sanofi$740
  • Novartis$623
  • Regeneron Healthcare Solutions, Inc.$609
  • plus $4K from 24 others

What the payments were for

  • Food & beverage$9,36794%
  • Education$6046%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,971 in reported general payments places this provider in the 95th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Medicare billing

Part B allowed, 2024
$347,903
Medicare patients
1,104
Services billed
6,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab19$124,016
Dupixent SyringeDupilumab13$44,201
Pimecrolimus16$7,459
Clobetasol Propionate128$7,213
Econazole Nitrate59$2,885
Desonide28$2,719
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc116$2,506
Ketoconazole184$2,306
Metronidazole44$2,190
Triamcinolone Acetonide139$2,048
Tacrolimus17$1,771
Doxycycline Monohydrate50$1,542
Clindamycin Phosphate47$1,308
Hydrocortisone119$1,002
Fluorouracil15$990

Paid to pharmacies, not to this prescriber.

Other medical in Millersville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →